Exfoliative dermatitis

L12_EXFOLIATIVE

atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L26
Cause of death: ICD-10 L26
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 L26

3 out of 7 registries used, show all original rules.

304

diagram downward connector

Check minimum number of events None

304

diagram downward connector

Include endpoints None

304

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

298

diagram downward connector
L12_EXFOLIATIVE

Control definitions

Control exclude L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L20-L30
Name in latin Erythrodermia universalis NAS

Summary Statistics

Key figures

All Female Male
Number of individuals 298 86 212
Unadjusted prevalence (%) 0.08 0.04 0.13
Mean age at first event (years) 58.78 53.41 60.95

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_EXFOLIATIVE – Exfoliative dermatitis
GWS hits:

Survival analyses between endpoints

Plot

before Exfoliative dermatitis
after Exfoliative dermatitis

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Exfoliative dermatitis

Endpoint not on priority list, no data to show.